FOXP3 and myeloid sarcoma: In MS patients, Tregs are deficient or defective in the blood, brains, and cerebrospinal fluid (CSF), characterized by reduced expression of the Forkhead box P3 (Foxp3) protein (37), which impairs their ability to adequately suppress the immune response of T cells towards the myelin basic protein (38).